Press releases

Stockholms läns landsting has as the first health care district in Sweden decided to
introduce DiBiCol on the list of reimbursed diagnostic tests. Approximately 15 000 out of a 1.5 million…

InDex Pharmaceuticals today announced that the first patent concerning the diagnostic test DiBiCol has been granted in Japan. With DiBiCol, the new and unique PCR-based test, inflammatory bowel…

Efficacy Demonstrated One Week after Single Dose Treatment The Swedish biopharmaceutical company InDex Pharmaceuticals AB today announced it has successfully concluded a clinical phase II proof of…

InDex Pharmaceuticals today announced that the last patient has now been recruited to
its clinical Phase II study of Kappaproct, for treating steroid resistant/dependent patients
with ulcerative…